MedTrace Logo

Liver and Spleen Stiffness to Predict the Presence of Esaphageal Varices in Cirrhotic With Advanced HCC

NCT06773260 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-01-22

No results posted yet for this study

Summary

Elasto-HCC is a prospective, uncontrolled, multicenter observational study involving several hepatology centers in Italy. Patients with liver cirrhosis and advanced hepatocellular carcinoma (HCC) who will need to undergo systemic therapy will be enrolled. Patients in the first phase will undergo measurement of liver and spleen stiffness and upper endoscopic evaluation and will subsequently be followed for 12 months

Conditions

Interventions

DIAGNOSTIC_TEST

Liver and Spleen stiffness measurement.

The use of spleen stiffness measurement to reduce unnecessary upper digestive endoscopies has never been evaluated in this patient setting.

Sponsors & Collaborators

  • Azienda Ospedaliero Universitaria Policlinico Modena

    lead OTHER

Principal Investigators

  • Alessandra Pivetti, MD · Azienda Ospedaliera Universitaria Policlinico Modena

  • Luigi Colecchia, MD · IRCCS Azienda Ospedaliero-Universitaria, Bologna

  • Elton Dajti, MD · IRCCS Azienda Ospedaliero-Universitaria, Bologna

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-20
Primary Completion
2025-06-15
Completion
2025-10-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06773260 on ClinicalTrials.gov